During thymic development,  T cells commit to either an IFN--or an IL-17-producing phenotype through mechanisms that remain unclear. Here, we investigated whether the SLAM/SAP signaling pathway played a role in the functional programming of thymic  T cells.
hardwired transcriptional programs (27) (28) (29) . Exactly how these seemingly independent mechanisms converge to regulate the developmental programming of innate-like  T cell subsets remains an open question.
Slam receptors comprise a family of nine cell surface receptors, SLAMF1 (SLAM; CD150), SLAMF2 (CD48), SLAMF3 (Ly9; CD229), SLAMF4 (2B4; CD244), SLAMF5 (CD84), SLAMF6 (Ly108; CD352, SLAMF7 (CRACC; CD319), SLAMF8 (BLAME), and SLAMF9 (SF2001; CD84H), that are expressed primarily on hematopoietic cells and which play diverse roles in immune development and function (30) . Most Slam receptors interact in a homophilic manner and therefore serve as self-ligands, the exception to this rule being the heterophilic interaction between SLAMF4 and SLAMF2. SLAM receptor signals can be both activating or inhibitory, depending on balanced recruitment of the cytosolic signaling adapter proteins SAP (31) and EAT-2 (32) , and inhibitory SHP-1 or SHIP phosphatases to immunoreceptor tyrosine switch motifs in the SLAM family receptor cytoplasmic domain.
Inactivation of the gene encoding SAP (Sh2d1a) disrupts the signaling pathway of the majority of SLAM family receptors and results in the development of the primary immunodeficiency X-linked lymphoproliferative disease (XLP) which is characterized by broad immunological defects, among which is a failure in iNKT cell development (33, 34) .
Interestingly, the only other lymphocyte subset in mice whose development is dependent on SAP expression is the V1V6.3 (NKT) T cell subset (35) , indicating that the requirement for SLAM/SAP signaling during development is shared by NKT cells and at least one  T cell subset. Yet, very little is known regarding SLAM family receptor expression on  T cells in either the periphery or the thymus. In this study, therefore, we explored whether the Single cell suspensions from skin were prepared as described (37) . Briefly, depilated skin was digested in Trypsin/GNK buffer (0.3% bovine pancreatic trypsin (Type XI) (Sigma), 5 mM KCl, 150 mM NaCl, and 0.1% glucose, pH 7.6) for 2 h at 37 o C., after which the epidermis was separated from the dermis. Epidermis was then placed in Trypsin/GNK buffer containing 0.5% DNase I, and incubated for 15 min at 37 o C. After incubation, samples were passed through 70 m mesh, washed with DMEM + 10% FBS, and resuspended in RPMI 1640 supplemented with 2 mM l-glutamine, 50 μM 2-mercaptoethanol, 50 U/ml penicillin, 50 ug/ml streptomycin + 10 U/ml IL-2 and incubated overnight at 37 o C in a 5% CO2 incubator prior to staining.
Liver intrahepatic leukocytes (IHLs) were isolated as previously described (38) . Briefly, livers were perfused through the portal vein with PBS, subsequently removed, minced, and gently pressed through nylon mesh. The resulting cell suspension was washed twice and then resuspended in isotonic 33.8% Percoll (GE Healthcare). After centrifugation, the IHL cell pellet was resuspended, washed with PBS, and red blood cells were lysed using Gey's solution.
Single cell suspensions were resuspended in flow cytometry staining buffer.
Intestinal Intraepithelial Lymphocytes (IEL) were isolated as previously described (39) .
Briefly, mouse small intestines were flushed with cold CMF buffer (1 mM Hepes, 2.5 mM NaHCO3, 2% FBS in Ca 2+ /Mg 2+ -free HBSS pH 7.2). Surrounding fat tissue was removed, intestines opened with a longitudinal incision, and excess mucous removed by gentle scraping.
Tissue was cut into small pieces, washed 3 times with CMF, followed by shaking in CMF+10% FBS/1 mM Dithioerythritol (DTE) for 20 minutes at 37 o C. This step was repeated and the cells in the supernatants of both extractions were combined. Cells were incubated for 20 minutes at 4 o C, before transferring cell supernatants into a fresh tube. Cells were centrifuged, washed once with RPMI, before resuspending in 44% Percoll solution. Cells were overlaid on a 67%
Percoll solution, spun for 20 minutes at room temperature. Cells at the interface were collected, washed twice with RPMI, prior to counting and further analysis.
For all tissues, cell numbers were determined on a MACSquant VYB (Miltenyi) using PI (1 ug/ml in PBS) for dead cell exclusion. Cell stimulations were conducted in Bruff's medium (Click's medium (Sigma) supplemented with 2 mM l-glutamine, 50 μM 2-mercaptoethanol, 50 g/ml gentamycin, 50 U/ml penicillin, 50 ug/ml streptomycin, and 5% FBS) with 25 ng/ml PMA and 500 ng/ml ionomycin for 4 hours at 37 o C and 5% CO2. After 2 hours, 2 M monensin was added to the culture.
Flow Cytometry
Cells were stained with Live Dead Fixable Blue staining reagent (ThermoFisher, Grand Island, NY) at 4°C in PBS for 30 min., after which they were washed and resuspended in PBS/2% FCS containing 0.1% sodium azide and Fc-Block (Biolegend) to block non-specific antibody binding prior to the addition of antibodies. Brilliant Violet Staining buffer (BD Biosciences) was used in experiments containing more than one Brilliant Violet or Brilliant Ultraviolet fluorophore conjugated antibody. To identify the V6 subset, the staining procedure described in Roark et al. was followed (40) .
Cells were washed twice with PBS/2% FCS/0.1% sodium azide solution and fixed in PBS/1% PFA buffer. For intracellular cytokine staining, cells were permeabilized with PBS/1% FCS/0.1% sodium azide/0.1% saponin after surface staining and fixation. 25 g/ml total rat IgG were added to reduce unspecific binding prior to cytokine staining with fluorescent-labeled antibodies. Nuclear transcription factors were analyzed using the Foxp3 transcription factor fixation/permeabilization reagent (ThermoFisher). Briefly, after staining for surface markers cells were resuspended in the fixation/permeabilization reagent and incubated overnight at 4 o C. Cells were washed, incubated with 25 g/ml total rat IgG prior to adding antibodies against transcription factors. After staining at 4  C, cells were washed and resuspended in PBS/2% FCS/0.1% sodium azide. Flow cytometry data were collected on a LSRII flow cytometer (BD Bioscience) and analyzed with FlowJo software (Treestar).
Antibodies used in these experiments were: CD11b (M1/70), CD19 (1D3), CD24 (M1/69), CD27 (LG.3A10), CD44 (IM7), CD45 (30-F11), CD48 (HM48-1), CD84 (mCD84.7), CD150 (TC15-12F12.2), CD229 (Ly9ab3), CD352 (330-AJ), IFN-g (XMG1.2), IL-17A (TC11-18H10.1), TCR (H57-597), TCR (GL3), V1 (2.11), V5 (536) from Biolegend; CD196 (140706), CD244 (2B4), RORt (Q31-378) from BD Biosciences; CD244.1 (C9.1), CD352 (13G3-19D), Eomes (Dan11mag), V4 (UC3-10A6) from eBiosciences.
t-SNE analysis
Dimensionality reduction of flow cytometry data was conducted using t-stochastic neighbor embedding (t-SNE) analysis in FlowJo. First, traditional gating was used to identify  T cells, after which the  T cell node data from 5 individual mice was concatenated and exported for further analysis. t-SNE analysis was conducted on the SLAMF1, SLAMF4, SLAMF6, V1, V4, V6, CD44, and CD27 parameters using the following conditions: 1000 iterations, perplexity = 40, learning rate = 436.
Transcriptional profiling
Leukocytes from lung cell preparations were isolated using anti-CD45 Microbeads and LS columns according to the manufacturer's instruction (Miltenyi). Cells were stained with Fixable Viability Dye eFluor780 (eBioscience), washed, and surface stained with Abs against SLAMF1, SLAMF6, NK1.1, TCR, TCR-V1, TCR-V4, TCR CD11b, CD19, and CD45 in sterile PBS/2% FBS. Cells were sorted on a FACS Aria III (BD Bioscience) into culture medium, pelleted, washed, and snap frozen until later use. RNA was isolated using a RNeasy Micro kit (Qiagen). RNA quality was assessed using an Agilent Bioanalyzer 2100, and RNA concentration was calculated using a Qubit fluorometer (ThermoFisher Scientific). Amplified cDNA was prepared using the Ovation Pico WTA System V2 (Nugen), and biotinylated using the Encore biotin module (Nugen). Hybridization with GeneChip Mouse Gene 2.0 ST arrays (Affymetrix) was conducted overnight at 45 o C. at 60 rpm. CEL files were analyzed using Transcriptome Analysis Console (ThermoFisher) software. Genes that demonstrated a greater than or less than 2-fold difference in expression and a false-discovery rate of <0.2 were identified. This resulted in 316 SLAMF1-enriched genes and 229 SLAMF6-enriched genes.
These gene lists were filtered by removing unannotated transcripts, predicted transcripts, and by removing all but 1 of the 28 multiple transcript isoforms of Syne1, yielding 244 SLAMF1enriched and 181 SLAMF6-enriched transcripts. All differentially expressed genes in this list exhibited a p-value < 0.004. The raw data files for this analysis were deposited in NCBI GEO (GSE128544).
Data were analyzed for gene ontological and pathway enrichment using NIH DAVID analysis and IPA (filtered to include only those with a p-value and FDR <0.05). Heatmaps were generated using prettyheatmap with row-scaling. Upstream regulator prediction using IPA analysis was conducted on the 425 differentially expressed genes based on fold-change (SLAMF1 + SLAMF6 -/SLAMF1 -SLAMF6 + ). The result was filtered to include only those predicted regulators with p-value of overlap < 1 X 10 -5 , ranked according to activation z-score, after
Statistical analysis
Statistical analysis was performed using Prism (GraphPad Software, San Diego, CA).
Unpaired Student t-tests, one-way ANOVA, or two-way ANOVA was used where appropriate.
For ANOVA posttest comparisons, the Dunnett, Tukey, or Sidak multiple comparison tests were used where appropriate. In all cases, tests were considered significant when p < 0.05.
Unless otherwise indicated, error bars represent standard deviation.
Results:
Heterogeneous SLAM receptor expression profiles on thymic  T cell subsets.
 T cell effector functions are largely programmed during thymic development, and IL-17 functional programming is thought to occur primarily during embryonic and neonatal thymic development (21) . Therefore, we examined the co-expression of SLAMF1 through SLAMF6 receptors on  T cell subsets from C57BL/6 embryonic day 17 (E.17) thymus. This analysis revealed that SLAMF5 was not expressed on  T cells and that the expression of SLAMF2 and SLAMF3 was relatively uniform among  T cell subsets (Fig. 1A) . In contrast, our analysis revealed that the other three receptors SLAMF1, SLAMF4, and SLAMF6 exhibited a surprising degree of heterogeneity in their co-expression ( Fig. 1B) . For example, a significant fraction of E.17 thymic  T cells were SLAMF1 -SLAM4 + SLAMF6and this population consisted primarily of V5  T cells (Fig. 1C) . Mature V5 in the skin exhibit the same SLAMF1 -SLAMF4 + SLAMF6phenotype, suggesting that the V5 SLAM receptor expression profile is established during embryonic thymic development ( Fig. 1D) (41) . Likewise, we observed that V6  T cells were primarily SLAMF1 + SLAMF4 -SLAMF6in the E.17 thymus, similar to the SLAM receptor expression profile that they exhibit in the adult lung (Figs. 1B and 3A).
In contrast to the V5 and V6 populations, E.17 V1 and V4 exhibited broad expression of SLAMF1 and SLAMF6 and they were uniformly SLAMF4 - (Fig. 1B) . We identified both SLAMF1 and SLAMF6 single positive (SP) populations that were present in peripheral tissues, as well as a SLAMF1SLAMF6 double positive (DP) population that was relatively rare in the periphery (Fig. 1B and Fig. 3A) . Interestingly, further investigation revealed that the SLAMF1SLAMF6 DP population was largely contained within the CD24 hi  T cell population, while the SLAMF1 and SLAMF6 SP populations, were primarily CD24 low .
These observations suggested that immature CD24 hi  T cells exhibited a SLAMF1SLAMF6 DP phenotype that resolved into either CD24 low SLAMF1 or SLAMF6 SP phenotypes or a SLAMF1SLAMF6 DN upon maturation (Fig. 1E ).
Since it was previously reported that IL-17-producing  T cells preferentially express SLAMF1 (42) , we asked whether the association of SLAMF1 receptor expression with IL-17 was established during thymic development. Interestingly, we found that RORt + E.17  T cells were largely found in a SLAMF1 hi SLAMF6 low  T cell subset ( Fig. 1F ) and that majority of IL-17-producing  T cells were SLAMF1 + , while the majority of IFN--producing  T cells were SLAMF1 - (Fig. 1G) . Taken together, these data suggested that the co-expression of SLAMF1, SLAMF4, and SLAMF6 distinguished 3 groups of  T cell subsets at E.17: V1/V4, V5, and V6. Moreover, the data suggested that immature thymic V1 and V4  T cells initially possess a SLAMF1SLAMF6 DP profile, and then develop into either SLAMF1 or SLAMF6 single positive expression profiles concomitant with maturation and acquisition of function.
Impaired  T development in SAP-deficient mice SLAMF1, SLAMF4, and SLAMF6 transduce signals by utilizing the signaling adapter proteins SAP and EAT-2, which binds to immunoreceptor tyrosine switch motifs (ITSMs) located in the cytoplasmic tails of SLAM family receptors (30) . Sh2d1a (encoding SAP) is the most widely expressed of these adapter proteins in  T cells and SAP-deficient mice have previously been reported to be deficient in the V1V6.3 (NKT) subset (43) . To determine whether the SLAM/SAP signaling pathway played a role in the functional programming that  T cells undergo during thymic development, we examined  T cell development in SAPdeficient mice during embryonic and neonatal stages of development.
A comparison of thymic  T cells between B6 and B6.SAP-deficient mice revealed no significant change in the distribution of V1, V4, V5, or V6  T cell subsets ( Fig. 2A) , although we did confirm the critical role of SAP in the development of the V1V6.3 subset (Suppl. Fig. 1 ). An examination, however, of the SLAM receptor expression profiles on E.17  T cells revealed a significant decrease in the frequency of SLAMF1 SP V1 and V4 T cells ( Fig. 2B) . The reduction in the SLAMF1 SP subset coincided with a significant increase in the frequency of SLAMF1SLAMF6 DP subsets in B6.SAP -/mice both at E.17 ( Fig. 2B ) and at day 6 (Suppl. Fig. 1 ). In accordance with our previous observation that SLAMF1SLAMF6 DP and SLAMF1 and SLAMF6 SP T cells were CD24 hi and CD24 low , respectively (Fig. 1D) , we observed a significant decrease in the frequency of CD24 low thymic V1 and V4  T cells in SAP-deficient mice (Fig. 2C) . No effect of SAP deficiency in CD24 expression on V6 subsets was observed (not shown). Together, these data suggested that SAP plays a role in the maturation of V1 and V4  T cells during thymic development.
Next, we assessed whether SAP-deficient thymic  T cells exhibited any functional defects. Examination of the E.17 CD44 + RORt +  T cell population revealed a significant decrease in the frequency of CD44 + RORt +  T cells in SAP-deficient mice (Fig. 2D) .
Significant decreases were observed in the V1, V4, and V1 -4 -5subsets, but not V5, very few of which were CD44 + RORt + (Fig. 2D) . Examination of neonatal day 5 thymocytes revealed that the SAP-dependent decrease in CD44 + RORt +  T cells was not restricted to embryonic thymic development, as there was a significant decrease in the frequency of CD44 + RORt + V4 T cells, which comprise the majority of thymic  T cells at this stage of development ( Fig. 2E) . However, the SAP-dependent decrease in CD44 + RORt + V1 and V1 -4 -5 -(primarily V6 at this stage of development) populations was not observed in the neonatal thymus ( Fig. 2E) .
Finally, we investigated whether SAP played a role in the acquisition of  T cell function during thymic development. A comparison of E.17  T cell cytokine production between B6 and B6.SAP -/mice revealed a significant decrease in both IL-17 and IFN- production in SAPdeficient mice (Fig. 2F ). Subset analysis revealed that the reduction in IFN- production was due primarily to an effect on V5  T cells ( Fig. 2G ), while the reduction in IL-17 production was instead observed in both V1 and V4  T subsets ( Fig. 2H) . No significant decrease in the IL-17-producing V1 -V4 -V5population was observed at this time, suggesting that development of the V6 population was SAP-independent (data not shown).
Analysis of later stages of development revealed that the effect of SAP deficiency was dependent on both the subset and developmental stage. A significant effect of SAP deficiency was observed on thymic V4 IL-17 production at all stages examined except for day 0.
Conversely, we found that V4 IFN- production was significantly decreased in SAP-deficient mice on day 0, but not any of the other timepoints examined. Similarly, we noted decreased thymic V1 IL-17 in B6.SAP -/mice only at E.17, and decreased thymic V1 IFN- only on days 5 and 7 (Fig. 2H ). Together, these data suggested that the SLAM/SAP signaling pathway played a significant role in the developmental programming of thymic V1, V4, and V5 IL-17 and IFN- production during embryonic and neonatal thymic development. In addition, the data suggested that impairments in the developmental programming of  T cells was linked to a SAP-dependent role in  T cell maturation.
Tissue-specific heterogeneity in SLAM receptor expression profiles on  T cell subsets in the periphery.
Next, we examined the extent to which SAP-dependent impairments in thymic  T cell development affected  T cell function in peripheral tissues. We first assessed the coexpression of SLAMF1 through SLAMF6 on  T cell subsets from different tissues. Similar to our results in the thymus, we found little evidence of SLAMF5 expression, and we found uniform expression SLAMF2 and SLAMF3 on  T cells and from the lung, spleen, and lymph node (Suppl. Fig. 2 ). In contrast, our analysis revealed a significant degree of heterogeneity in SLAMF1, SLAMF4, and SLAMF6 co-expression on  T cell subsets obtained from different tissues (Fig. 3A) . In the lung, we found two distinct populations of V1 and V4  T cells which were either SLAMF1 SP or SLAMF6 SP. In contrast, V6  T cells were uniformly SLAMF1 SP with no detectable SLAMF6 expression ( Fig. 3A) . A similar SLAM receptor expression pattern was observed in the spleen although the frequency of the SLAMF1 SP V4 T cell population was markedly reduced compared with the lung and essentially absent in the V1 subset (Fig.   3A ). In contrast to lung and spleen, a significant proportion of SLAMF4-expressing  T cell subsets were detected in the liver, while gut IEL  T cells only expressed SLAMF4, and not SLAMF1 or SLAMF6 (Fig. 3A) .
Heterogeneity in SLAM family receptor co-expression was also observed in BALB/cJ  T cells, which possess a different Slam haplotype (44) (Fig. 3B ). We did note significant differences between the strains indicating that SLAM receptor co-expression profiles were influenced by genetic background. Notably, we observed a significantly greater proportion of SLAMF1 + SLAMF6lung and spleen Vγ4 T cells in BALB/c compared to their B6 counterparts ( Fig. 3B) . Together, these data indicated that the co-expression of SLAM family receptors on  T cells constituted unique SLAM receptor expression profiles that varied in both a tissuedependent and V subset-dependent manner. The data also indicated that the SLAM receptor expression profiles of  T cell subsets in the periphery largely reflect those established during thymic development, and suggested that they are relatively stable markers that result from a developmental program.
SLAM receptor expression profiles distinguish  T cell functional subsets in the periphery.
Given the association of SLAMF1 expression with T cell IL-17 production in the thymus (Fig. 1G ), we were interested in determining whether distinct SLAM receptor expression profiles marked functional subsets of  T cells in the periphery. We focused our attention on lung  T cells, since they exhibited a diversity of SLAM family receptor expression profiles. Analysis of the co-expression of SLAM family receptors with the surrogate functional markers, CD44 and CD27, on lung  T cells revealed that SLAMF1 + SLAMF6 - T cells were primarily CD44 + CD27 - (Fig. 4A ) consistent with an IL-17-producing phenotype (42) .
Interestingly, SLAMF1 -SLAMF6 +  T cells were primarily CD44 -CD27 + suggestive of an IFN-producing phenotype, while SLAMF4-expressing  T cells were distributed in both CD44 + CD27and CD44 -CD27 + populations (Fig. 4A) . Therefore, SLAMF1 and SLAMF6 expression in the periphery coincided with canonical markers of IL-17 and IFN--producing T cells, respectively.
To determine whether SLAM receptor expression profiles marked functional subsets of  T cells, we assessed lung  T cell cytokine production after stimulation with PMA/ionomycin. These data revealed that lung  T cell IFN- production was associated with SLAMF1 -SLAMF6 +  T cells, while IL-17 production was associated with SLAMF1 + SLAMF6 - T cells (Fig. 4B) . Similarly, stimulation of both spleen and IFN- production, respectively. Together, these data suggested that the mutually exclusive expression of SLAMF1 and SLAMF6 marked IL-17-and IFN--producing V1, V4, and V6  T cell subsets in the periphery.
To explore this association further, we compared the ex vivo transcriptional profiles of sorted lung SLAMF1 + SLAMF6and SLAMF1 -SLAMF6 + lung V4 from naïve C57BL/6J mice. This analysis revealed the differential expression of 244 genes in SLAMF1 + SLAMF6and 181 genes in SLAMF1 -SLAMF6 + lung V4 (Fig. 5A , Suppl. Table 1 ). In accordance with our functional analysis, we found that SLAMF1 + SLAMF6lung V4  T cells exhibited a transcriptional profile highly suggestive of IL-17 production. We observed differential expression of Il23r, Il17a, Il17f, Il1r1, Blk, Rorc, Sox13, Maf, Ccr6, Ccr2, and Scart2 all of which have been previously associated with a T17 phenotype (27, 28, 45) (Fig. 5A and Suppl. Table 1 ). In contrast, the transcriptional profile of the SLAMF1 -SLAMF6 + V4  T cells was suggestive of an IFN--producing phenotype. Ifng, Eomes, IL12rb, and Crtam were preferentially expressed in SLAMF1 -SLAMF6 + V4  T cells ( Fig. 5A and Suppl. Table 1 ).
These findings were consistent with a recent report demonstrating that EOMES expression marks IFN--producing  T cells (46) . Pathway analysis (IPA) of differentially expressed genes revealed that transcripts enriched in SLAMF1 + SLAMF6lung V4 cells exhibited significant overlap with genes regulated by ZBTB16 (PLZF), IL23R, RORT, and IL-1B. In contrast, transcripts enriched in SLAMF1 -SLAMF6 + lung V4 exhibited significant overlap with genes regulated by IL-12, TBX21 (T-bet), IFN- IL-27, and TCF3 (E2A) ( Fig. 5B and Suppl. Table 2 ). These transcriptional profiles were confirmed using flow cytometry which revealed that RORt expression was largely confined to the SLAMF1 + SLAMF6 -T cells in both lung and lymph node, while EOMES expression was found in the SLAMF1 -SLAMF6 +  T cell subsets (Fig. 5C ). Together, these data suggested that lung SLAMF1 + SLAMF6and SLAMF1 -SLAMF6 + V4  T cells possessed transcriptional profiles consistent with IL-17 and IFN- production, respectively.
Impaired  T function in SAP-deficient mice
Finally, we examined the extent to which impaired thymic  T cell developmental programming in SAP-deficient mice affected  T cell function in peripheral lung and lymphoid organs. A comparison of neonate lung  T cells between B6 and B6.SAP -/mice revealed that there was a significant decrease in lung V4 IL-17, but not IFN-, production ( Fig. 6A ) and this decrease corresponded to a significant decrease in SLAMF1 + IL-17 + V4 cells (Fig. 6B) . No difference was observed in either lung V1 IL-17 or IFN- production (Fig. 6A) , nor did we 20 observe any SAP-dependent decrease in V6 IL-17 production (data not shown). Interestingly, the SAP-dependent decrease in V4 T cell IL-17 production did not persist in the adult lung.
Instead, a comparison of adult lung  T cell cytokine production between B6 and B6.SAP -/mice revealed a significant decrease in both lung V1 and V4 IFN- production (Fig. 6C) . We again noted no SAP-dependent decrease in V6 IL-17 production (data not shown). A comparison of adult spleen V1 and V4 cytokine production between B6 and B6.SAP -/mice also revealed significantly less IFN- in SAP-deficient V1 and V4 T cells than in their B6 counterparts, indicating that the SAP-dependent decrease was not tissue-specific (Fig. 6D) .
Together, these data demonstrated that  T cell IL-17 and IFN- production in the periphery was significantly impaired in SAP-deficient mice. In addition, the data indicated that the SAPdependent impairment in  T cell function in the periphery was both age and subsetdependent.
Discussion
Here, we identified the SLAM/SAP signaling pathway as a critical regulator of the functional programming that generates IL-17 and IFN--producing  T cells during thymic development. We found that maturation of thymic V1 and V4, was associated with a transition from a SLAMF1SLAMF6 DP phenotype to either SLAMF1 or SLAMF6 SP or A number of studies support a model in which high-affinity binding of  TCR during development promotes differentiation toward IFN- producing cells, while low-affinity interactions favor programming for IL-17 production (22) (23) (24) (25) (26) 47) . In light of our findings indicating that both IL-17 and IFN- production are altered in SAP-deficient mice, it is interesting to note that SLAM receptor signaling has previously been shown to modulate TCR signaling thresholds in conventional  T cells (48) . In addition, recent reports indicate that the NKT cell differentiation is regulated by TCR signal strength (49, 50) , and that the net effect of SLAM receptor signaling is a reduction in NKT TCR signal strength (51) . It is possible, therefore, that SLAM/SAP signaling influences  T cell developmental programming through the modulation of TCR signals. SP  T cells is consistent with a role for SAP in both the maturation and acquisition of function. Because the co-expression of both SLAMF1 and SLAMF6 on immature CD24 hi  T cells puts them in an optimal position to influence TCR signal strength, it could be possible that SLAM/SAP signaling modulates the TCR signals received by the immature  T cell, thereby influencing its differentiation. An important caveat to this model is that the frequency and function of V6 T cells, whose development has been demonstrated to be influenced by TCR signal strength (25) , did not appear to be dependent on SAP. Whether the effect of SAP is due to its effect on TCR signaling, or is due to a TCR-independent process will require additional investigation.
Increasing evidence suggests that the development of IL-17-and IFN--producing  T cells is also regulated by TCR-independent mechanisms.  T cell development is dependent on a characteristic subset of transcription factors including SOX4, SOX13, Blk, c-maf, HEB, and PLZF, among others (27, 28, 45, (52) (53) (54) . Recently, it was reported that at least some T17 programming results from a SOX13-dominated transcriptional hard-wiring of early thymocyte precursors (29) . These SOX13 progenitors appear to give rise to IL-17-producing V4, but not V6 cells. Our observation that V4, but not V6 subsets are SAP-dependent are therefore consistent with a role for SLAM receptors and SAP in the initiation of a transcriptional program critical for the acquisition of function. Indeed, because SLAM receptors are expressed on hematopoietic stem cells (55) (56) (57) , they are in a position to influence  T cell programming at the earliest stages of development.
Our findings demonstrate the presence of distinct SLAM family receptor expression profiles on  T cell subsets in the periphery that are tightly associated with function. These findings not only confirm a previous report that SLAMF1 marks T17 cells (42), they reveal the presence of a mutually exclusive expression pattern of SLAMF1 and SLAMF6 on  T cells that is tightly associated with distinct transcriptional programs and with IL-17 and IFN- production, respectively. The finding that SLAM family receptor expression patterns are established during thymic development, and that they are already associated with function as early as embryonic day 17, suggests that they result from a developmental program.
In support of this notion, significant changes in SLAMF1, SLAMF4, SLAMF6, and SLAMF7 expression have been described on B cells as they progress through developmental stages (58) , and SLAM receptor expression profiles on hematopoietic stem cell and multipotent progenitor cell populations (55) have recently been demonstrated to mark functionally distinct progenitor populations (57) . Together, our findings suggest the possibility that the coordinate signaling of distinct arrays of SLAM family receptors plays a role in the development of  T cells in the thymus. This would be consistent with reports indicating that multiple SLAM receptors are involved in NKT cell development (34, 51, 59, 60) , and may explain the inability to observe T17 defects in mice lacking only a single SLAM family receptor (42) .
Our observations indicated that SAP deletion did not completely abolish the development of IL-17-producing V4, but instead reduced their numbers in thymus and neonatal lung by approximately 40%. This finding likely suggests the existence of one or more specific SAP-dependent V4 subsets, as is the case with the V1 T cell population that is composed of the SAP-dependent V1V6.3 subset and other SAP-independent subsets.
Recent data demonstrating that the TCR repertoire of IL-17-producing V4 T cells is highly restricted (61, 62) , suggests the possibility that the partial decrease in V4 IL-17 production observed here may be due to a complete failure in the development of a specific IL-17producing V4 subset. Such a model is also consistent with the observation that the SAPdependent decrease in lung  T cell IL-17 production observed in neonates was not consistently observed in adult mice. We speculate that the restricted development of IL-17producing V4 T subsets to embryonic and neonatal thymus (21) γδ Slamf1   ZBTB16  STAT3  USP17L9P  IL23R  IL2  ICOS  IL23  RORC  IL1B  CD3 group  IL12B  NFATC2  ITK 
